NCT00347802View on ClinicalTrials.gov

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Glaucoma
Interventions
DRUG

Bimatoprost 0.03%, Travoprost 0.004%

Trial Locations (1)

15213

Dr. Noecker, Pittsburgh

Sponsors

Lead Sponsor

Innovative Medical
All Listed Sponsors
lead

Innovative Medical

INDUSTRY